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Phosphatidylserine is  a derivative of phosphatidic acid,  in which a 
phosphoric acid is  bound by an ester l inkage to the hydroxyl group of a  
serine moiety.  Recently,  not only L-serine but also D-serine has been 
shown to occur as a base moiety of the phospholipids found in various 
rat  t issues.  In this study, we showed the occurrence of 
phosphatidyl-L- threonine (PThr),  phosphatidyl -L-aspartate (PAsp),  and 
phosphatidyl-L-glutamate (PGlu) in rat  brain.  Analyses using  an 
HPLC-ESI-MS and an amino acid analyzer showed the presence of  
L- threonine, L-aspartate,  and L-glutamate in the acid-hydrolysates of 
phospholipids from porcine cerebrum, rat  cerebrum, and rat  l iver.  
Results of ESI-MS/MS analyses with neutral  loss scanning and product  
ion scanning suggest  the presence of PThr-(18:0,  18:1),  PThr-(18:0,  
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22:6),  PAsp-(18:0,  18:1),  PAsp-(18:0,  22:6),  PGlu-(18:0,  18:1),  and 
PGlu-(18:0,  22:6) in rat  brain.  This is  the first  study to identify  2 novel  
phospholipids,  PAsp and PGlu, with a carboxylate -phosphate anhydride 
bond, in l iving organisms.  
 
Keywords:  aspartate,  glutamate,  threonine, phospholipids,  mammal,  
carboxylate-phosphate anhydride  
 
Abbreviations:  Boc-L-Cys,  N- tert-butyloxycarbonyl-L-cysteine;  CEM, 
channel electron multiplier voltage; CM, carboxymethyl;  DHA, 
docosahexaenoic acid;  ESI,  electrospray ionization;  HPLC, high 
performance l iquid chromatography; IS, ion spray voltage; MS, mass 
spectrometry;  NMDA,  N-methyl-D-aspartate;  OPA, o-phthaldialdehyde; 
OR, orifice voltage; PAsp, phosphatidyl -L-aspartate;  PGlu,  
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phosphatidyl-L-glutamate;  PS, phophatidylserine; L-PS, 
phosphatidyl-L-serine;  D-PS, phosphatidyl -D-serine;  PThr,  
phosphatidyl-L- threonine; RNG, focusing  ring voltage; THF, 
tetrahydrofuran; TLC, thin -layer chromatography; 18:0,  stearic acid;  
18:1,  oleic acid;  22:6,  docosahexaenoic acid.  
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1. Introduction  
 
Phospholipids are  the major l ipid components of biological  
membranes,  in which sn-glycero-3-phosphate is  esterified at  i ts C1 and 
C2 posit ions by fatty acids and at  i ts  phosphoryl group by various bases 
such as choline,  ethanolamine, and serine.  Thus far,  only 2 types of 
L-amino acid-containing phospholipids,  i .e. ,  phophatidylserine (PS) and 
phosphatidylthreonine (PThr),  have been identified in biological  samples.  
PS is  a component of mammalian cell  membranes and plays an important 
role in biological  processes such as apoptosis [1 -4] and cell  signaling 
[5-8].  Although i t  was long believed that  phosphatidyl -L-serine (L-PS) 
was the only PS occurring in l iving organisms [9-11],  we recently 
discovered a D-serine-containing phospholipid,  phosphatidyl -D-serine 
(D-PS),  in rat  cerebrum [12] and other t issues [13].  Meanwhile,  PThr has 
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been found in eggs [14],  tuna muscle [15],  polyoma virus-transformed 
hamster embryo fibroblast s  [16],  and hippocampal neurons cultured in a 
medium without serine [17].  However,  i t  is  st i l l  unclear whether PThr or 
D-PS plays any role in l iving organisms.  
Both L-PS and PThr are synthesized  by base-exchange reactions,  in 
which the polar head groups of preexisting phospholipids are replaced by 
serine and threonine, respectively [17 -20].  Similarly,  D-PS has been 
suggested to be formed via  a base-exchange mechanism, according to  our 
previous finding of an endogenous activity through which free D-serine 
was incorporated into phospholipids from rat  cerebrum extract  [12].  This  
raises the question of whether other amino acids ,  besides serine and 
threonine, are incorporated as base moieties in phospholipids in vivo .  In 
our previous studies [12, 13],  we have noticed that  threonine, aspartate,  
and glutamate are  also present  in the l ipid hydrolysates of rat  t issues. In 
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this study, we analyzed  the hydrolysates of porcine cerebrum by  using 
HPLC-ESI-MS analysis and those of rat  cerebrum and l iver by  using an 
amino acid analyzer.  Through ESI-MS/MS analysis of  the phospholipids 
from rat  cerebrum, we showed that  threonine, aspartate,  and glutamate 
indeed occurred as the head groups of phospholipids found in rat  
cerebrum. To our knowledge, this is  the first  report of  naturally 
occurring phospholipids possessing a carboxylate -phosphate anhydride 
bond.  
 
2. Materials and methods  
 
2.1. Materials  
 
o-Phthaldialdehyde (OPA) and a Cosmosil  5C1 8-AR-II column (4.6 
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  150 mm) were purchased from Nacalai  Tesque (Kyoto, Japan).  
N- tert-Butyloxycarbonyl-L-cysteine (Boc-L-Cys) was purchased from 
Novabiochem (La Jolla,  CA, USA). A preparative thin -layer  
chromatography (TLC) plate (Sil ica Gel 60 glass plate) was purchased 
from Merck (Darmstadt,  Germany).  A carboxymethyl (CM) -cellulose 
column was purchased from Whatman International Ltd (Maidstone, UK). 
All  other chemicals were of analytical  grade.  
 
2.2. Extraction and purif ication of  l ipids  
 
Crude l ipids were extracted from porcine b rain (1 g) by using 
Folch’s method [21].  To further purify the l ipids,  0.2 volumes of 0.9% 
KCl was added to the crude l ipid extract ,  and the mixture was 
centrifuged at  100 × g  for  20 min at  ambient temperature.  The 
10 
 
chloroform phase was collected and dried under a stream of nitrogen gas.  
The purified l ipids were resuspended in chloroform and stored at  –20°C 
unti l  use.  
Male Std:Wistar rats (Japan SLC, Inc. ,  Japan) at  postnatal  week 7 
were euthanized and their  cerebrums were extirpated. The extraction and 
purification of crude l ipids were performed using the abovementioned 
procedures.  PS-rich phospholipids were isolated from the purified l ipids 
by preparative TLC by using the solvent system consist ing of 
chloroform/methanol/acetic acid/water (65/25/2/4,  v/v) [1 6] and by 
CM-cellulose column chromatography [22].  The purified phospholipids 
were stored at  –20°C unti l  use.  
 




Phospholipids were hydrolyzed by boil ing  them in 1 ml of 6 M HCl 
for 6 h.  The hydrolysate was mixed with 9  volumes of 
chloroform/methanol/water (27:13:5,  v/v) and centrifuged at  100 × g  for  
20 min. The aqueous fraction containing amino acids was collected and 
stored at  –20°C unti l  use.  
 
2.4. Amino acid analysis  
 
 The aqueous fraction was applied to a Hitachi L -8500 amino acid 
analyzer equipped with  a packed column for physiological  fl uid analysis  
(Hitachi Ltd. ,  Tokyo, Japan).  
 




 Amino acids were derivatized using OPA and Boc-L-Cys according 
to the method described by Hashimoto  et  al .  [23].  
 
2.6. HPLC-ESI-MS analysis  
 
 Boc-L-Cys-OPA amino acid  derivatives were separated using an 
HPLC system (Shimadzu, Kyoto, Japan) equipped with  a Cosmosil  
5C1 8-AR-II column (4.6   250 mm) operated at  0.8 ml/min at  20°C with a 
l inear gradient from 20% to 40% mobile phase B over a period o f 20 min. 
Mobile phase A consisted of 0.1 M acetate buffer (pH 6.0),  7% 
acetonitri le,  and 3% tetrahydrofuran (THF), and mobile phase B 
consisted of 0.1 M acetate buffer (pH 6.0),  47% acetonitri le,  and 3% THF, 
according to previous ly described methods [23].  The flow rate of the 
eluent from the HPLC column was spli t  in to a ratio of 1:16 such that  
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only 50 μ l /min of the eluent  entered the mass spectrometer.  The mass 
spectrometric measurements were performed using an API 3000 tr iple 
quadrupole instrument (PE Sciex, Toronto, Canada).  To measure the 
negative ion spectra,  we set  the ion spray voltage (IS),  orifice voltage 
(OR), focusing ring voltage (RNG), and Channel Electron Multiplier  
voltage (CEM) at  –4.0 kV, –30 V, –200 V, and 2.2 kV, respectively.  The 
instrument was calibrated using a polypropylene glycol solution. 
Nitrogen was used as  the nebulizer gas,  curtain gas,  and coll ision gas.  
The data were acquired over the mass ranges of 421 –424, 435–437,  
450–454, and 463–467  m/z .  
 
2.7.  ESI-MS/MS analysis  
 
 Purified phospholipids in chloroform were dried under a stream of 
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nitrogen gas and resuspended in acetonitri le/methanol (2/1,  v/v) 
containing 0.1% ammonium formate (pH 6.5).  The l ipid solution was 
injected into the ESI-MS/MS system (PE Sciex, Toronto, Canada) and 
analyzed using the neutral  loss scan and product ion scan modes.  In both 
the scan modes,  IS,  OR, RNG, CEM, and coll ision energy  were set  at  
–5.0 kV, –80 V, –200 V, 2.8 kV, and 51 eV, respectively.  A syringe 
infusion pump (Harvard Apparatus,  Cambridge, MA) delivered solvent at  
2.5 μ l /min to the ESI probe. The l ipid solution was introduced using a 
100-μ l  glass syringe with a stainless steel  needle (Hamilton Co.,  Reno,  
NV).  
 
3. Results  
 





To investigate whether amino acids other than serine can exist  as  
the base moiety of phospholipids,  l ipids from porcine cerebrum were 
hydrolyzed with HCl. The hydrolysate s were derivatized using OPA and 
Boc-L-Cys [23] and subjected to HPLC-ESI-MS analysis.  As shown in 
Fig.  1A, 3 peaks were detected at  6.86, 8.74, and 13.82 min in addition 
to those representing derivatives of D-serine (12.72 min) and L-serine 
(11.76 min).  The m/z  values of the peaks at  6.86, 8.74, and 13.82 min 
were 451,  465, and 437, respectively,  which  matched the m/z  values of 
the Boc-L-Cys-OPA derivatives of authentic L-aspartate,  L-glutamate,  
and L- threonine, respectively. The retention t imes of the 3 peaks were 
also consistent with those of the authentic derivatives of L-aspartate,  
L-glutamate,  and L-threonine (data not shown). The 3 peaks were not  
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detected in the l ipid samples that  were boiled in water instead of HCl 
(Fig.  1B),  and this finding confirmed that  the l ipid samples wer e not 
contaminated by free amino acids.  These results suggest  that  L-aspartate, 
L-glutamate,  and L- threonine occur as  base moieties of phospholipids in 
porcine cerebrum.  
 
3.2. Analysis of  phospholipid hydrolysates from rat cerebrum and l iver  
 
To further examine whether aspartate, glutamate,  and threonine 
can be l iberated from phospholipids by hydrolysis,  we extracted l ipids 
from rat  l iver and isolated a PS-rich phospholipid fraction by using TLC 
and CM cellulose column chromatography. Because the mobili ty of PThr 
and PS is indist inguishable  on TLC plates and CM cellulose columns 
[16],  i t  was expected that  the PS-rich phospholipid fraction  would at  
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least  contain PThr.  The purified PS-rich fraction was hydrolyzed by HCl 
and analyzed using an amino acid analyzer.  As shown in Fig.  2A, peaks 
corresponding to not only serine and thr eonine but also aspartate and 
glutamate were detected. We also similarly analyzed the hydrolysate of a  
PS-rich fraction obtained from rat  cerebrum and detected aspartate,  
glutamate,  and threonine in addit ion to serine as the products of 
phospholipid hydrolysis (Fig.  2B).  These results strongly suggest  that  
not only serine and threonine but also aspartate and glutamate exist  as  
acid-hydrolyzable moiet ies of phospholipids in  the cerebrum and l iver of 
rats.  Our data also suggest  that  the mobili ty of phospholip ids containing 
aspartate and glutamate is  similar to that  of PS and PThr under TLC and 
CM-cellulose column chromatography conditions.  
 




According to the results described above, if  aspartate and 
glutamate are bound to phosphatidic acid to form carboxylate -phosphate 
anhydride,  then phosphatidyl -L-aspartate (PAsp)  and 
phosphatidyl-L-glutamate (PGlu) are expected to occur in rat  t issues (Fig. 
3).  To confirm this hypothesis,  we analyzed  the phospholipids found in  
rat  brain by performing fragmentation reactions of the polar head groups 
of phospholipids during ESI-MS/MS. Fragmentation reactions allow 
specific detection of a  phospholipid species by neutral  loss scanning.  
Through this technique, i t  was shown that  PS and PThr can be selectively 
detected by a neutral  loss of 87 Da [24, 25] and 101 Da [26],  
respectively (Scheme. 1).  Accordingly,  when similar fragmentation 
reactions occur in PAsp and PGlu, i t  is  expected that  neutral  losses of 
115 Da and 129 Da,  respectively,  should be observed. As expected, our 
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ESI-MS/MS analysis of phospholipids found in rat  brain detected neutral 
loss peaks of 115 Da and 129 Da (Fig.  4B and 4C). The neutral  loss  peak 
of 101 Da, corresponding to PThr,  was also detected (Fig. 4A) . These 
data suggest  that  PAsp and PGlu as well  as PThr do occur in fractions of 
rat  brain phospholipids .  
Furthermore, we performed product ion scanning of the following 
peaks,  identified as major  peaks by the neutral  loss scan: m/z  802.7 and 
848.7 corresponding to PThr (Fig.  5A and 5B), m/z 816.7 and 862.7 
corresponding to PAsp (Fig.  5C and 5D), and m/z  830.3 and 876.8 
corresponding to PGlu (Fig.  5E and 5F).  The product ion scans detected 
several  peaks that  can be assigned to fatty acid fragments (Fig.  5).  The 
fragments at  m/z  281.5,  283.5,  and 327.5 were identified as  the anions of 
oleic acid,  stearic acid,  and docosahexaenoic acid (DHA), respectively.  
The fragment at  m/z  153 was consistent with  the 1,2-cyclic  
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phosphodiester of glycerol,  which is a product  ion from every 
glycerophospholipid [24, 25].  These results suggest  the presence of  
PThr-(18:0,  18:1),  PThr-(18:0,  22:6),  PAsp-(18:0,  18:1),  PAsp-(18:0,  




We previously showed that  D-PS occurs in  rat  cerebrum and 
various other  rat  t issues.  We also showed that  free D-serine can be 
incorporated into PS in an in vitro  system by using cerebrum extract ,  
suggesting that  D-PS is formed by a base-exchange reaction [12, 13].  In 
mammals,  free  D-serine is  distr ibuted in  the cerebrum [27, 28] and plays 
an important role as a coagonist  of the glycine si te of 
N-methyl-D-aspartate (NMDA) receptors [29, 30].  The intracellular  
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D-serine levels are regulated by serine racemase [31, 32] and D-amino 
acid oxidase with its effector pLG72 [33].  In addition, PS is an abundant  
component of membranes of brain cells ,  and thus,  our previous results  
suggest  that  the synthesis and degradation of D-PS affects the 
intracellular D-serine levels,  thereby modulating  neurotransmission.  
In this study, we found that  amino acids other  than D-  and L-serine 
occur as the base moieties of phospholipids in porcine and rat  brains.  
From our data,  these amino acids were determined to be L- threonine, 
L-aspartate,  and L-glutamate.  L-Threonine,  in addit ion to  serine,  
possesses a hydroxyl group in i ts  side chain and thus probably es terifies 
at  the phosphoryl group of a sn-glycero-3-phosphate  phospholipid 
backbone. In contrast ,  the side chain s of L-aspartate and L-glutamate 
contain a carboxylate group. Therefore,  we propose that  these 
dicarboxylic amino acids form a carboxylate -phosphate anhydride bond 
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with phosphatidic acid.  To our knowledge, this is  the fir st  study that  
showed the presence of phospholipids with a carboxylate -phosphate 
anhydride bond.  No other  amino acids,  except  serine,  threonine, 
aspartate,  and glutamate ,  were detected in our HPLC-ESI-MS and amino 
acid analyses.  Especially,  hydroxyl -containing tyrosine and homoserine 
and reactive thiol -containing cysteine and homocysteine were not  
detected in the l ipid hydrolysates.  This f inding indicates that PThr,  PAsp, 
and PGlu are not nonspecific resultant products,  which could have been 
indist inguishably formed by the base-exchange reactions of 
phospholipids .  Instead,  they are possibly synthesized by particular  
metabolic reactions.  Although a wide variety of -carboxyl 
group-containing amino acids  exists,  only L-aspartate and L-glutamate,  
in addit ion to L- threonine and L-  and D-serine were found in the l ipid 
hydrolysates.  Therefore,  we propose that  the carboxylate -phosphate 
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anhydride bond in PAsp and PGlu is formed between the phosphoryl  
group of a  phospholipid and the distal  carboxyl groups (i .e. ,  -carboxyl 
and -carboxyl) of L-aspartate and L-glutamate.  Unlike D-PS, D-aspartate 
was not found in the hydrolysate of phospholipids despite the fact  that a 
considerable  amount of D-aspartate occurs in various endocrine t issues 
[28, 34, 35] to regulate producti on and/or secretion of specific hormones 
[36,  37].  However,  this is  not unexpected because Hashimoto et al .  
reported that  significant considerable  amount of free D-aspartate is  not  
present in rat  cerebrum at postnatal  week 7 [28].  I t  will  be interesting to  
analyze hydrolysates of phospholipids from testis ,  which contain  
relatively high concentrations of free D-aspartate [28],  to examine the 
presence of  phosphatidyl-D-aspartate . 
I t  has already been reported that  PThr occurs in several 
mammalian cells,  fish,  and eggs [14-17].  Although the physiological  
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function of PThr remains unknown, i ts  putative metabolic pathway has 
been suggested. I t  is  thought that  PThr can be synthesized by a 
base-exchange enzyme that  also catalyzes the synthesis of PS [17] and  
can be decarboxylated to yield phosphatidylisopropanolamine by PS 
decarboxylase [26].  I t  has been proposed that  PThr is  synthesized 
instead of PS when the intracellular levels of se rine are insufficient for  
the synthesis of PS [17].  However,  the results of the present study 
suggest  that  PThr appears to be consti tutively present in both normal rat  
brain and normal porcine liver.  This implies  an as of yet  unknown 
biological role played by PThr in mammals.  
On the other hand, the metabolic pathway of PAsp and PGlu 
remains unclear.  There is  no reported evidence that  PS synthase or PS 
decarboxylase acts on phospholipids possessing a carboxylate -phosphate 
anhydride bond. This raises an interesting question about the metabolism 
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of phospholipids.  I t  is  known that  aspartate a nd glutamate act  as 
neurotransmitters involved in learning and memory in mammalian brains 
[38,  39].  Thus, PAsp and PGlu are potentially related to th ese neural  
processes through regulation of  the brain levels of free aspartate and 
glutamate.  
Our MS/MS analyses showed that  PThr,  PAsp, and PGlu  each 
contain either a set  of oleic acid and stearic acid or a set  of oleic acid 
and DHA as the fatty acid moieties.  Polyunsaturated fatty acids play 
essential roles in the development and function of the brain [40 -42].  In 
particular,  decreased levels of DHA in the brain and retina are associated 
with impairments in neural  and visual functions [43 -45].  PS contains a 
high proportion (>35%) of DHA as a fatty acid moiety [46].  I t  is  thought 
that  the developmental  disorder o f the central  nervous system observed 
in fetal  alcohol syndrome is partly due to a decreased level of 
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DHA-containing PS [47-50].  Further studies are needed to investigate 
the potential  biological  roles played by the DHA-containing 
phospholipids discovered in this study.  
 
5. Conclusions  
 
We investigated the base moieties of phospholipids found in rat  
brain and l iver and porcine cerebrum by a combination of HPLC -ESI-MS 
analysis,  amino acid analysis,  and ESI -MS/MS analysis followed by 
neutral  loss scanning and  product ion scanning. Our data suggest  the 
presence of  PThr-(18:0,  18:1),  PThr-(18:0,  22:6),  PAsp-(18:0,  18:1),  
PAsp-(18:0,  22:6),  PGlu-(18:0,  18:1),  and PGlu-(18:0,  22:6) in 
mammalian t issues.  This study is the first  to identify  naturally occurring 
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Fig. 1.  HPLC-ESI-MS analysis of  the acid-hydrolysates of l ipids from 
porcine brain.   
(A) PS was hydrolyzed using 6 M HCl for 6  h.  Free amino acids were 
isolated and derivatized using Boc-L-Cys and OPA. (B) PS was boiled in 
water  instead of HCl.  The aqueous fraction was isolated and applied to 
the derivatization procedure.  Data were acquired over the mass range s of 
421–424, 435–437, 450–454, and 463–467 m/z .  The molecular masses of 
serine,  threonine, aspartate,  and glutamate derivatives were 424, 438,  
452, and 466 Da,  respectively.  The peaks of the Boc -L-Cys-OPA 
derivatives of L-aspartate,  L-glutamate,  L- threonine, L-serine,  and 




Fig. 2.  Amino acid analysis of  the acid-hydrolysates of l ipids  found in 
rat  cerebrum and l iver.   
A chromatogram of amino acids  detected in a hydrolysate of rat  l iver 
phospholipids (A) and rat  cerebrum phospholipids (B),  which were 
purified by preparative TLC and CM -cellulose column chromatography, 
is  shown. The peaks representing aspartate,  threonine, glutamate,  and 
serine are indicated by a ,  b ,  c ,  and d ,  respectively.  
 
Fig. 3.  Structures of PS, PThr,  PAsp, and PGlu.  
The known structures of PS (A) and PThr (B) and the proposed structures 
of PAsp (C) and PGlu (D) are shown.  
 
Fig. 4.  ESI-MS/MS analysis with neutral loss scanning of  the 
phospholipids detected in rat  brain.   
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Data of mass spectrometr ic analyses are shown:  PThr with a neutral loss 
of 101 Da (A),  PAsp with a neutral  loss of 115 Da (B),  and PGlu with a 
neutral  loss of 129 Da (C).  The inset  of each panel shows the assumed 
fragmentation reaction in ESI -MS/MS. 
 
Fig. 5.  ESI-MS/MS analysis with product ion scanning of  the 
phospholipids found in rat  brain.  
Product ion spectra of each [M-H]
-
 ion, indicated in Fig.  3 ,  with a 
molecular mass of 802.7 Da (A),  848.7 Da (B),  816.7 Da (C),  862.7 Da 
(D),  830.3 Da (E),  and 876.8 Da (F),  a re shown. The peaks corresponding 
to a glycerol phosphate fragment,  stearic acid (18:0),  oleic acid (18:1),  
and docosahexaenoic acid (22:6) are also indicated.  
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